VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC
77.69 USD -1.24 (-1.57%)
At closeNov 5, 2026, 4:00 PM EST
77.69 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
77.61 Day range 79.54
64.72 52-week range 79.54
- YTD
- +17.91%
- 1 year
- +19.76%
- Market cap
- 757.35M
- EPS (ttm)
- 4.68
- P/E ratio
- 16.62
- YTD return
- +17.91%
- 1-year return
- +19.76%
- Volume
- 17.66K
- Avg volume
- 13.89K
- Open
- 79.49
- Previous close
- 78.93
- Day's range
- 77.61 – 79.54
- 52-week range
- 64.72 – 79.54
1D -1.24 (-1.57%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 65.24
- 200-day average
- 61.60
About VictoryShares US EQ Income Enhanced Volatility Wtd ETF
The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets directly or indirectly in the securities included in the Nasdaq Victory U.S. Large Cap 100 High Dividend Long/Cash Volatility Weighted Index. The index identifies the 100 highest dividend yielding stocks in the Nasdaq Victory U.S. Large Cap 500 Volatility Weighted Index.
News
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer 
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (NASDAQ:CDC) to Issue Monthly Dividend of $0.20 
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (NASDAQ:CDC) Share Price Break Below 50-Day Moving Average – Here’s Why 
Claritev Selected by GDIT to Support CDC's World Trade Center Health Program 
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand 
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency 
Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director 
600-horsepower 2027 Dodge Charger Super Bee Launch Edition Storms the Hive as Quickest, Fastest, Most Powerful Dodge Super Bee Ever 
Chipotle Stock Extends Slide After CDC Links Salmonella Outbreak to Jalapeños 
Baby formula maker Nara issues US-wide recall after FDA, CDC flag infant botulism cases
Your note
Sign in to keep a note on CDC — it syncs with the Stock Master app.